Nuzenio

Safety Profile

Safety Profile news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Lobeglitazone Shows Long-Term Renal Safety in T2DM, Including CKD Patients : Study - Medical DialoguesMedical Dialogues · Sat, 08 Aug 2026 04:00:10 GMT Clesrovimab shows comparable safety to palivizumab in high-risk infants across 2 RSV seasons - Contemporary PediatricsContemporary Pediatrics · Fri, 07 Aug 2026 17:56:30 GMT Dr Thomas on the Safety Profile of Frontline Ipatasertib Plus Pembrolizumab in HNSCC - OncLiveOncLive · Thu, 06 Aug 2026 21:37:16 GMT FDA Approves Moderna's mRNA-Based Flu Vaccine - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 13:07:44 GMT Consistent Safety Profile of Risankizumab Across Psoriasis and Psoriatic Arthritis - HCPLiveHCPLive · Thu, 06 Aug 2026 12:05:44 GMT Atacicept Shows Encouraging Safety Profile in IgA Nephropathy: Richard Lafayette, MD - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Wed, 05 Aug 2026 16:41:27 GMT Real-world safety profile of fezolinetant: a disproportionality analysis based on the FAERS database - Springer Nature LinkSpringer Nature Link · Tue, 04 Aug 2026 08:30:24 GMT Researchers develop new antifungal compounds with improved safety profile - PharmafilePharmafile · Wed, 29 Jul 2026 09:41:00 GMT

Timeline

Sat, 08 Aug 2026 04:00:10 GMTLobeglitazone Shows Long-Term Renal Safety in T2DM, Including CKD Patients : Study - Medical Dialogues

Fri, 07 Aug 2026 17:56:30 GMTClesrovimab shows comparable safety to palivizumab in high-risk infants across 2 RSV seasons - Contemporary Pediatrics

Thu, 06 Aug 2026 21:37:16 GMTDr Thomas on the Safety Profile of Frontline Ipatasertib Plus Pembrolizumab in HNSCC - OncLive

Thu, 06 Aug 2026 13:07:44 GMTFDA Approves Moderna's mRNA-Based Flu Vaccine - Pharmaceutical Executive

Thu, 06 Aug 2026 12:05:44 GMTConsistent Safety Profile of Risankizumab Across Psoriasis and Psoriatic Arthritis - HCPLive

Wed, 05 Aug 2026 16:41:27 GMTAtacicept Shows Encouraging Safety Profile in IgA Nephropathy: Richard Lafayette, MD - The American Journal of Managed Care® (AJMC®)

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Managed Care3 live mentions AJMC3 live mentions Springer Nature Link3 live mentions Term Renal Safety2 live mentions Including CKD Patients2 live mentions RSV2 live mentions Frontline Ipatasertib Plus2 live mentions Pembrolizumab2 live mentions Based Flu Vaccine2 live mentions Risankizumab Across Psoriasis2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Safety Profile.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.